# Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study

> **NCT04669990** · — · UNKNOWN · sponsor: **Nepal Health Research Council** · enrollment: 2000 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Remdesivir

## Key facts

- **NCT ID:** NCT04669990
- **Lead sponsor:** Nepal Health Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-19
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-11-19
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04669990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04669990, "Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04669990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*